Exclusive

Publication

Byline

Andelyn Biosciences partners Queen's University on AAV9-GM2 gene therapy manufacturing

Singapore, Aug. 19 -- Andelyn Biosciences has partnered with Queen's University to develop and manufacture AAV9-GM2, an investigational gene therapy for GM2 gangliosidoses, including Tay-Sachs and San... Read More


CanSinoBIO's Td5cp adolescent and adult vaccine NDA accepted in China

Singapore, Aug. 19 -- CanSino Biologics has announced that China's National Medical Products Administration has accepted the New Drug Application for its Tetanus, Reduced Diphtheria and Pertussis (Ace... Read More


Singapore approves GSK's Blenrep combinations for treatment of relapsed/refractory multiple myeloma

Singapore, Aug. 19 -- GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved Blenrep for the treatment of adults with relapsed or refractory multiple myeloma in co... Read More


LEO Pharma buys Tanabe's rare disease drug dersimelagon for $435 M

Singapore, Aug. 18 -- LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an agreement to acquire worldwide rights to dersimelagon fro... Read More


Lonza launches rapid custom media prototyping service for early bioprocess development

Singapore, Aug. 18 -- Switzerland-based Lonza, the world's leading contract development and manufacturing organization (CDMO), has announced its Rapid Media Prototyping Service (RaMP), giving biopharm... Read More


Singapore tackles healthcare challenges with interdisciplinary approach

Singapore, Aug. 18 -- Nanyang Technological University (NTU), OUE Limited and its healthcare subsidiary, OUE Healthcare, have announced a set of collaboration initiatives to advance holistic healthcar... Read More


Australia's Monash University and Vietnam's Becamex Group sign MoU to advance science, technology

Singapore, Aug. 18 -- Australia-based Monash University has signed a Memorandum of Understanding (MoU) with Vietnam's Becamex Group, establishing a strategic partnership to support the development of ... Read More


Everest Medicines' LEROCHOL BLA accepted in China for hypercholesterolemia

Singapore, Aug. 18 -- Everest Medicines has announced that China's National Medical Products Administration has accepted the Biologics License Application for LEROCHOL (lerodalcibep), a third-generati... Read More


Apodex launches TRACES benchmark to evaluate AI for scientific discovery

Singapore, Aug. 18 -- Apodex has launched TRACES, a benchmark designed to evaluate how artificial intelligence systems perform on open-ended scientific problems where the correct answer may not yet be... Read More


Nominations Open for the BioSpectrum Asia Excellence Awards 2026

Singapore, Aug. 17 -- BioSpectrum Asia opened nominations for the BioSpectrum Asia Excellence Awards 2026, the 20th anniversary edition of the region's most established life sciences publication. Entr... Read More